Latest Episodes
mCRC: Optimising patient outcomes with late-line treatment
What treatment options are available for patients with metastatic colorectal cancer who have already progressed through multiple lines of therapy? How can we select...
Perseverance pays off – Looking beyond the obvious mutations in NSCLC
Why is it important to perform comprehensive molecular testing in non-small cell lung cancer to look beyond the obvious mutations? Which biomarker tests are...
Ovarian cancer: Pre-analytical phase challenges and biomarker testing
What are the common pre-analytical phase challenges in ovarian cancer, and how can we overcome them? Why is it important to identify genetic alterations? ...
Lung cancer: Pre-analytical phase challenges and biomarker testing
What are the common pre-analytical phase challenges in lung cancer, and how can we overcome them? Why is it important to identify genetic alterations?...
Treatment optimisation in mCRC: third line and beyond
Treatment of advanced colorectal cancer should be considered a continuum of care and patients should be offered as many life prolonging therapies as possible. ...
Precision oncology: An overview of tumour agnostic therapies
What are tumour agnostic cancer treatments and which biomarkers do they target? Join Prof. David Hong (Medical Oncologist at MD Anderson Cancer Center, Houston,...